Sign in

You're signed outSign in or to get full access.

Jessica Maher

Director at FONAR
Board

About Jessica Maher

Jessica Maher (age 27) is an independent director of FONAR, serving since March 2023. She is a staff accountant at Ives & Sultan, LLP, with prior experience at PricewaterhouseCoopers, Northwell Health, and Tritech Healthcare Management; she holds a B.S. and M.S. in Accounting from Fairfield University. Her background centers on audit and financial reporting; she currently serves on FONAR’s Audit Committee alongside independent directors Ronald G. Lehman and Richard E. Turk .

Past Roles

OrganizationRoleScope/Impact
Ives & Sultan, LLPStaff AccountantPrepares audited financial statements; oversees audit testing; audits 401(k) plans; handles tax returns
PricewaterhouseCoopersAssociate (audit)Assigned to private equity clients; responsible for audit areas; assisted in reviewing financial statements, disclosures, and opinions
Northwell HealthFinance InternSupported financial reporting for two hospitals; worked in A/R systems; analyzed patient billing for overpayments
Tritech Healthcare ManagementAnalystReviewed patient files, insurance, charts; ensured correct billing by clients

External Roles

  • No other public company directorships disclosed in the proxy for Maher .

Board Governance

  • Independence: FONAR identifies Maher as independent under SEC and NASDAQ Marketplace Rules; no undisclosed transactions considered in that determination .
  • Committees: Audit Committee member (standing committee with a written charter; independent-only). Audit Committee members: Ronald G. Lehman (Chair, financial expert), Richard E. Turk, Jessica Maher .
  • Board structure: Controlled company—Chairman/CEO Timothy R. Damadian controls >50% of voting power; no standing compensation or nominating committees; management (CEO/COO) sets compensation .
  • Meetings: Board and Audit Committee met 4 times in fiscal year ended June 30, 2024 (individual director attendance not disclosed) .
  • Election results (May 19, 2025): Maher received 11,083,836 For; 1,664,116 Withheld; 1,559,986 Broker Non-Votes .

Fixed Compensation

Fiscal YearFees Earned in Cash ($)Stock Awards ($)Option Awards ($)Non-Equity Incentive ($)Nonqualified Deferred Earnings ($)All Other Compensation ($)Total ($)
202420,000 0 0 0 0 15,000 35,000
  • Director compensation minimum: $20,000 per annum for board service and any committee work (excluding the Chairman, who receives no board compensation) .

Performance Compensation

Fiscal YearRSU/DSU Grants (Shares/$)PSU Grants (Shares/$)Option Grants (Shares/$)Performance Metrics Tied to Director Pay
2024None disclosed (0) None disclosed (0) None disclosed (0) None disclosed
  • No director equity awards or performance-linked pay components disclosed for Maher in FY2024; no vesting schedules, clawbacks, severance, or change-of-control provisions disclosed for directors .

Other Directorships & Interlocks

EntityRole/InterestPotential Interlock/Conflict Context
Health Management Company of America (HMCA)Holds 0.015% interest in HMCA’s Class A membership interests HMCA is FONAR’s subsidiary managing imaging centers; multiple related-party transactions exist with entities owned or affiliated with CEO Timothy R. Damadian; directors Lehman and Chan also hold small HMCA interests

Expertise & Qualifications

  • Accounting credentials: B.S. and M.S. in Accounting; audit and financial reporting experience (public and healthcare) .
  • Committee-relevant skills: Audit testing oversight, 401(k) plan audits, and financial statement preparation align with Audit Committee responsibilities (Maher is a member; Lehman designated as the committee financial expert) .

Equity Ownership

Security ClassShares Beneficially OwnedPercent of Class
Common Stock0 <1%
  • No preferred or Class C holdings disclosed for Maher; officers and directors as a group own 137,721 common shares and 382,447 Class C shares (Class C controlled via trustee), underscoring controlled company status .

Say-on-Pay & Shareholder Feedback

ItemForAgainstAbstainBroker Non-Votes
Advisory vote on executive compensation (May 19, 2025)12,389,147 331,150 27,655 1,559,986
  • Auditors ratified: CohnReznick LLP for FY2025 (14,084,984 For; 83,704 Against; 139,250 Abstain) .

Governance Assessment

  • Strengths:

    • Independent director on a fully independent Audit Committee; committee oversees financial reporting and auditor independence .
    • Accounting-heavy background appropriate for audit oversight; helps board effectiveness despite her relatively early career stage .
    • Clean 10b5-1 disclosure: No adoption/termination of trading plans by directors in the quarter ended June 30, 2024 .
  • Concerns/Red Flags:

    • Controlled company dynamics: CEO controls >50% voting power, chairs the board, and, along with COO, sets executive and director compensation due to absence of a standing compensation committee—raises independence and pay governance concerns .
    • Related-party exposure: Small HMCA ownership interest (0.015%) for Maher; HMCA engages in material transactions with entities owned/affiliated with the CEO (e.g., imaging facility fees, equipment note) which can present perceived conflicts despite board-confirmed independence .
    • Ownership alignment: Maher holds zero common shares, and there are no disclosed director equity grants or ownership guidelines—limits “skin-in-the-game” signaling .
    • Limited committee structure: No nominating or compensation committees; nominations handled by full board; compensation set by management—unusual structure relative to best practices .

Overall signal: Maher strengthens the audit function with practical accounting expertise, but FONAR’s controlled-company governance (no comp committee, extensive related-party dealings, limited director equity alignment) constrains independence optics and may impact investor confidence in pay-for-performance alignment and conflict management .